Type 2 diabetes (T2D), which affects many people around the world, is one of the diseases
that is on the rise. Various studies have revealed that insulin resistance and lessened insulin …

Type 2 diabetes mellitus raises the risk of cardiovascular disease since it is a chronic
metabolic infection (CVD). Glycosuria is a side effect of the most recent anti-diabetic …

A chronic metabolic disease, diabetes mellitus (DM), is associated with various
comorbidities that considerably decrease the quality of life. Sodium glucose linked …

Type 2 diabetes mellitus is a chronic metabolic disease associated with high cardiovascular
(CV) risk. Sodium-glucose co-transporter 2 inhibitors (SGLT2i) are the latest class of …

Sodium-glucose cotransporter inhibitors (SGLT2i) play an increasingly important role in type
2 diabetes mellitus (T2DM) due to their significant cardiovascular benefits and renal …

Background Conventional therapies to prevent type 2 diabetes mellitus (T2DM)
complications are only partially effective. Therefore, new therapeutic approaches leading to …

Diabetes mellitus (DM) with uncontrolled blood sugar causes a variety of problems,
including coronary artery disease, stroke, heart failure, hypertension, nephropathy …

Diabetes mellitus (DM) is one of the most prevalent diseases of modern society. There are
several therapeutic options available, but they also have many shortcomings. With the …

The sodium-glucose co-transporter 2 inhibitors (SGLT2 inhibitors) are newly introduced
adjuvant antidiabetic medications that block the reabsorption of glucose in the area of …

Purpose of Review Type 2 diabetes mellitus (T2DM) is a prevalent disease with the severe
clinical implications including myocardial infarction, stroke, and kidney disease. Therapies …